“THAT WAS A DEFINITE WIN! IT WAS A SLAP IN THE FACE TO MODERNA. THEY DIDN’T MEET SAFETY STANDARDS…THEY’RE DEFINITELY APPEALING THIS PROCESS.” Dr. Ben Tapper from The Wellness Company discusses the HHS cutting more than $700M in the experimental mRNA bird flu contract.